- Abstract Number: 2908
T cell Engager treatment in systemic sclerosis
- Abstract Number: 1289
T-cell Subset Analysis Reveals Disease-Specific Alterations and systemic lupus erythematosus-Activity-Associated Subsets
- Abstract Number: 0935
T-Cell-Bound Complement Activation products and T-Cell directed autoantibodies (TC4d, TIgM) Are Associated With Primary Antiphospholipid Syndrome and APS-SLE Overlap
- Abstract Number: 1975
T1 IFN Activity In Systemic Sclerosis Is A Molecular Endotype With Asymmetric Temporal Variability: Results From A Longitudinal Cohort
- Abstract Number: 0528
Tandem CD19/BCMA CAR T-Cell Therapy in Refractory or Progressive Systemic Sclerosis: Early Multidomain Clinical and Immune Remodeling
- Abstract Number: 0529
Tandem CD19/BCMA CAR T-Cell Therapy in Refractory/Progressive Systemic Sclerosis: Early Immune Remodeling and Skin Response
- Abstract Number: 1656
Target trial emulation studies of the effectiveness of sodium-glucose cotransporter-2 inhibitors vs. ACE inhibitors/angiotensin II receptor blockers for primary gout prevention and flare rates among patients with heart failure
- Abstract Number: 0156
Targeted Delivery of mRNA for In Vivo CAR-T Therapy Induces Deep B-Cell Depletion Across Blood and Lymphoid Tissues in Humanized Mouse and Nonhuman Primate (NHP) Models and in Ex Vivo SLE Patient Samples
- Abstract Number: 2514
Targeted Inhibition of IL-18 with Tadekinig Alfa Correlates with Disease Control of Primary Monogenic IL-18-driven Hyperinflammatory Syndrome, a Serious and Potentially Life-threatening Disease in Patients with NLRC4 and XIAP mutations
- Abstract Number: 0126
Targeting an IgA-CD89 Axis as a Therapeutic Strategy in Severe Rheumatoid Arthritis Patients
- Abstract Number: 1114
Targeting B-cell Maturation Antigen Using T-cell Engager in Autoimmune Diseases: Exploring the Mechanism of Circulating B-cell Depletion and soluble BCMA as a Biomarker of Tissular Plasma Cells
- Abstract Number: 1946
Targeting neutrophil cytoskeletal dysregulation in ANCA Associated Vasculitis
- Abstract Number: 2811
Targeting Neutrophil Extracellular Traps with DNase1 as a Disease-Modifying Strategy for the Treatment of Inflammasomopathies
- Abstract Number: 1947
Targeting Properdin with an Albumin-Binding Bispecific VHH Antibody Confers Preclinical Benefit in an Enhanced Rat Model of Autoimmune Vasculitis
- Abstract Number: 2028
Targeting Rheumatoid Arthritis with Myeloid-Directed JAK-Inhibiting Nanomedicine
- Abstract Number: 1048
Targeting RUNX3 Suppresses Tissue-Resident Memory T Cell Differentiation from Multilineage Progenitors in the Arthritic Synovium
- Abstract Number: 1957
Targeting the AHR Pathway with Tapinarof to Restore T Cell Balance in Systemic Lupus Erythematosus
- Abstract Number: 2055
Targeting the Progesterone Receptor as a Regulator of ECM Remodeling and Fibrosis in Osteoarthritis.
- Abstract Number: 2849
Targeting the Type I Interferon Pathway: Efficacy and Safety of Anifrolumab in Refractory Juvenile Dermatomyositis-A Multi-Center Experience
- Abstract Number: 2047
Targeting Xanthine Dehydrogenase Restores Mitophagy in Synovial Macrophages and Ameliorates Juvenile Idiopathic Arthritis
- Abstract Number: 2482
Teaching in the Digital Age: Using Social Media as a Knowledge Brokering Platform
- Abstract Number: 2966
Teaching Joint Self-Examination to Patients with Rheumatoid Arthritis Using a Low-Fidelity Hand Model
- Abstract Number: 1879
Technologist vs Physician FRAX: Systematic Underestimation of Fracture Risk at Higher Thresholds
- Abstract Number: 0747
Teclistamab-Induced Immune-Related Adverse Events in Autoimmune Diseases: Gastrointestinal Symptoms and Psoriasis
- Abstract Number: 1242
Telitacicept Reduces Disease Activity, Modulates B Cell Homeostasis and Interferon Signatures in Chinese Patients with Systemic Lupus Erythematosus: A Prospective Cohort Study
- Abstract Number: 1290
Telitacicept reshapes peripheral B- and T-cell compartments and interferon-related programs in systemic lupus erythematosus: insights from single-cell transcriptomic and B-cell receptor profiling
- Abstract Number: 2126
Temporal Artery Ultrasound for Giant Cell Arteritis: Real-World Diagnostic Performance at a U.S. Academic Center
- Abstract Number: 1767
Temporal Differences in Lipid Mediator Dynamics Associate with Progression to Inflammatory Arthritis in the TIP-RA Cohort
- Abstract Number: 0405
Temporal Dynamics and Discriminatory Power of Outcome Measures in Psoriatic Arthritis Clinical Trials
- Abstract Number: 0530
Temporal Patterns of LLM-Detected Mobility Impairment Before and After Incident Rheumatoid Arthritis
- Abstract Number: 0733
Temporal Shifts in Salmonella Bloodstream Infections Among Patients with Rheumatic Diseases: A 20-Year Single-Center Study
- Abstract Number: 0726
Temporal Treatment-Response Patterns Across Rheumatoid Arthritis Core Set Domains: A Patient-Level Analysis of Randomized Trials
- Abstract Number: 0830
Temporal trends and disparities in mortality due to connective tissue diseases and hypertension among older adults (≥ 55 years) in the United States 1999-2025
- Abstract Number: 2769
Temporal Trends and Disparities in Rheumatoid Arthritis-Associated Septicemia Mortality Among U.S Adults Aged 25 and Older in the United States, 1999-2025: A Retrospective Analysis
- Abstract Number: 1362
Temporal Trends and Risk Factors of Permanent Disability in Ankylosing Spondylitis: A Korean Nationwide Analysis
- Abstract Number: 2732
Temporal Trends in Clinician Use and Editing of AI Scribe-Generated Clinical Documentation
- Abstract Number: 1291
TEN-like Acute Cutaneous Lupus Erythematosus: Clinical Spectrum, Serological Associations, and Treatment Outcomes in Fourteen Patients from a Single Tertiary Centre
- Abstract Number: 0797
Ten-Year Trends in Rheumatology Medicare Utilization and Reimbursement for Diagnostic and Interventional Musculoskeletal Ultrasound (2013 to 2023)
- Abstract Number: 0018
TGF β1/Smad3/IL 9 Axis Drives Inflammation in Gout: A Novel Pro inflammatory Pathway and Potential Therapeutic Target
- Abstract Number: 1958
TH17 and ExTH17 Cells in Rheumatoid Arthritis-related Interstitial Lung Disease (RA-ILD)
- Abstract Number: 1818
The 2023 ACR/EULAR Criteria Reshape Population-Based Antiphospholipid Syndrome Epidemiology and Mortality Compared with the 2006 Sydney Criteria
- Abstract Number: 0284
The 5 mg/kg Hydroxychloroquine Dose Cutoff Is Not a Discrete Safety Threshold for Retinopathy and Trades Off Against SLE Flare Risk: A Global Individual Patient Data Meta-Analysis
- Abstract Number: 1907
The Aryl Hydrocarbon Receptor Establishes an Immunometabolic Positive Feedback Loop to Restrain Pathogenic B-Cell Differentiation in Systemic Lupus Erythematosus
- Abstract Number: 2515
The Association of Congenital Heart Disease and Severe Forms of Non-Systemic Juvenile Idiopathic Arthritis and Still’s Disease
- Abstract Number: 1820
The Association of Gout Flares and Subsequent Cardiovascular Events: Secondary Nested Case-Control Study of the CARES Trial
- Abstract Number: 0208
The Association of Venous Thromboembolism with Disease Manifestations in ANCA-Associated Vasculitis
- Abstract Number: 0963
The C5a/C5aR1 axis regulates multiple pathogenic pathways in giant-cell arteritis
- Abstract Number: 0209
The Canadian Registry of Avacopan for ANCA Vasculitis (CARAvAN) study: Outcomes at 6-Month Follow-up
- Abstract Number: 2910
The CD20xCD3 T-Cell Engager PRO-203 Induces Deep B-Cell Depletion and Clinical Improvement in Patients with Systemic Autoimmune Rheumatic Diseases – A Case-Series in Treatment-Refractory Patients
- Abstract Number: 2836
The CHAISE study: Clonal Hematopoiesis in AntIphospholipid SyndromE, an exploratory observational study
- Abstract Number: 2603
The CX3CL1-CX3CR1 Axis as a Key Prognostic Factor and Potential Therapeutic Target in Anti-MDA5 Dermatomyositis with Interstitial Lung Disease
- Abstract Number: 1464
The diagnostic performance of a novel test for rheumatoid arthritis: Results from a prospective early arthritis cohort study
- Abstract Number: 0923
The Disparate Effect of Statins on eGFR in Systemic Lupus Erythematosus
- Abstract Number: 2277
The Effect of Body Mass Index (BMI) on eGFR Decline in Systemic Lupus Erythematosus versus Lupus Nephritis
- Abstract Number: 2733
The Effect of Extended Pediatric Rheumatology Care on Gaps in Care in Young Adults: A Retrospective Cohort Study
- Abstract Number: 0641
The Effect of Low-Dose Radiation Therapy in the Management of Knee and Hand Osteoarthritis: A Single-Center Study
- Abstract Number: 1423
The effects of Janus kinase inhibitors on pain in rheumatoid arthritis: a systematic review and network meta-analysis
- Abstract Number: 0927
The efficacy of low-dose naltrexone in improving self-reported physical health in patients with vasculitis: The LoDoNaVasc trial
- Abstract Number: 0864
The Endogenous Ketone Body β-Hydroxybutyrate Restores Neutrophil Mitophagy and Reduces Thrombosis in Antiphospholipid Syndrome
- Abstract Number: 0865
The endothelial activation and stress index (EASIX) predicts Clinical Progression to Antiphospholipid Syndrome in Antiphospholipid Antibody Carriers
- Abstract Number: 2377
The Fascial-Neural Complex as a Sonographic Landmark for Ultrasound-Guided Parotid Biopsy: Anatomical and Clinical Validation
- Abstract Number: 2451
The Fast Track to Relief for Pain Beyond the Joints in RA: Can Rapid RA Control Mitigate the Impact of Non-articular Pain on Physical Function? A Real-World, Longitudinal Early RA Cohort Study
- Abstract Number: 2795
The Frequency of Overlap Between Calcium Pyrophosphate Deposition Disease and Hereditary Hemochromatosis
- Abstract Number: 2713
The Hidden Burden of SLE: A Parallel Survey Revealing Physician-Patient Gaps in Disease Control, Access, and Care Experience
- Abstract Number: 2734
The Hidden Economic Burden of Low Back Pain: Global Welfare Losses and National GDP Impact in 2023
- Abstract Number: 1913
The Impact of a Rheumatology Circuit Rider Program on Access to Care, Timeliness, and Mission Readiness in the U.S. Air Force
- Abstract Number: 0189
The Impact of Age on the Relation Between Adherence to Dietary Recommendations and the Risk of Developing Giant Cell Arteritis; a Nested Case-Control Study
- Abstract Number: 2127
The Impact of Aneurysm Presence on the Course of Takayasu Arteritis: A Retrospective Tertiary Center Experience
- Abstract Number: 2857
The impact of idiopathic inflammatory myopathies: A population-based cohort in England 2002 to 2021
- Abstract Number: 0247
The impact of NETosis on the Severity of Peripheral Vascular Involvement in Patients with Systemic Sclerosis
- Abstract Number: 2871
The impact of systemic autoimmune diseases on health-related quality of life: a longitudinal analysis of three prospective observational cohorts
- Abstract Number: 2536
The Impact of Tophi and Elevated Serum Urate (SU) Levels on Health-Related Quality of Life (HRQoL) and Daily Functioning in Patients (pts) With Uncontrolled Gout (UG)
- Abstract Number: 0667
The impact of various corticosteroid strategies on the progression of interstitial lung disease in idiopathic inflammatory myopathies
- Abstract Number: 0858
The Incidence of Infusion Reactions in Patients Receiving Rituximab After Pretreatment With Different Methylprednisolone Doses
- Abstract Number: 0157
The Inflammatory Cytokine Milieu Regulates the Fc Glycosylation Profile and Effector Function of Secreted IgG
- Abstract Number: 1292
The Invisible Burden of Lupus: Objective Evidence of Cognitive Fatigue and Reduced Neural Processing in systemic lupus erythematosus: A combined fMRI and eye-tracking study
- Abstract Number: 1578
The Landscape of Incident Knee Diagnoses in Adults That May Mimic Symptomatic Osteoarthritis at An Early Structural Stage
- Abstract Number: 1976
The Lipofibroblast to Myofibroblast Transition in Systemic Sclerosis
- Abstract Number: 2735
The Macroeconomic Burden of Osteoarthritis: Global, National, and Joint-Specific Welfare Losses in 2023
- Abstract Number: 2581
The Nerve to Relieve: A Systematic Review and Meta-Analysis of Safety and Efficacy of Vagal Nerve Stimulation in Low Back Pain Patients.
- Abstract Number: 1293
The Neuropsychiatric Systemic Lupus Erythematosus Biomarker Landscape: A Systematic Review and Meta-analysis of Blood and Cerebrospinal Fluid Analytes
- Abstract Number: 0248
The Nor-SSCardioCare Open-Label Clinical Pilot Trial: Home-Based Monitoring of Cardiopulmonary Complications in Systemic Sclerosis
- Abstract Number: 2770
The Opioid Gap in Rheumatoid Arthritis: CNS-Active Polypharmacy in National Outpatient Visits, 2006-2019
- Abstract Number: 2955
The Osteoporosis Value Paradox: Comparative Cost of Care for Cardiovascular Disease Versus Fragility Fractures and Implications for Secondary Prevention
- Abstract Number: 0138
The Overlapping Genetic Architecture of Rheumatoid Arthritis and Polymyalgia Rheumatica
- Abstract Number: 0606
The Patient Voice in Decentralized Clinical Trials: Acceptability, Operational Experience, and Future-Trial Preferences in Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease (IIM-ILD) from the MINT Patient Perspective Survey
- Abstract Number: 2657
The Pattern and Severity of Gout Flares Prior to and During Pegloticase Treatment in the MIRROR and AGILE Clinical Trials
- Abstract Number: 0406
The Performance of a New Definition of Sonographic Inflammatory Enthesitis at the Single-Enthesis Level for Discriminating Psoriatic Arthritis from Psoriasis Alone and Controls: Analysis of Data from the DUET study
- Abstract Number: 0436
The performance/applicability of the OMERACT Salivary Gland Ultrasound Scoring System for the evaluation of Lacrimal Glands in Sjögren’s Disease
- Abstract Number: 0762
The positive predictive value of hook-like osteophytes for hemochromatosis and calcium pyrophosphate disease
- Abstract Number: 2714
The Price of Relief: Insurance-Related Treatment Disruption After Medicare Transition in Inflammatory Arthritis
- Abstract Number: 2824
The Problem of Pain in SLE: Longitudinal Validation of Patient-Reported Nociplastic Symptom Phenotypes
- Abstract Number: 1604
The Prospective Registry Of MyositIS (PROMIS): Validation of the Classification Criteria for Anti-Synthetase Syndrome (CLASS) Project in a multicenter, large-scale cohort study
- Abstract Number: 1205
The Psychosocial Burden of Systemic Sclerosis-Associated Gastrointestinal Disease: A Qualitative Grounded Theory Study
- Abstract Number: 0831
The Relation of Sleep Patterns with Knee Pain and Functional Limitation in Knee Osteoarthritis: Data from the Osteoarthritis Initiative
- Abstract Number: 0510
The relations of Mediterranean dietary habit on the levels of gut permeability biomarkers in rheumatoid arthritis
- Abstract Number: 2312
The relationship between lifestyle factors and the treatment effectiveness of TNF-inhibitors in psoriatic arthritis – results from 12 European countries
- Abstract Number: 1465
The relationship between male rheumatoid arthritis associated interstitial lung disease and exposure to cigarette smoking and occupational inhalational vapors, gases, dusts and fumes
- Abstract Number: 1639
The Relationship between Smoking, Uveitis and Vision Loss: A Retrospective Study Using TriNetX, a Global Database
- Abstract Number: 1657
The Relationship in An Individual Between Urate Lowering Therapy Dose and Serum Uric Acid Before and After Pegloticase.
- Abstract Number: 0469
The RIN3/NLRC3/SLX4 Multiplex Genetic Panel as a Promising Potential Tool to Guide Precision Decisions of JAK Inhibitors in Rheumatoid Arthritis Patients
- Abstract Number: 2895
The Ripple Effect: An Innovative Train-the-Trainer Model for Axial Spondyloarthritis
- Abstract Number: 0065
The RNA-binding protein BTG1 exacerbates lupus nephritis by driving the abnormal differentiation of Th17 cells.
- Abstract Number: 1858
The Sjögren’s Tool for Assessing Response (STAR) demonstrates its ability to accurately detect treatment efficacy in 17 recent RCTs in Sjögren’s disease
- Abstract Number: 1489
The Tofu-Pasta-Cardstock Phantom Model for Teaching Ultrasound-Guided Procedures: 3 Years of Experience
- Abstract Number: 2826
The Transcriptional Profile of Circulating Monocytes is Associated with Nociplastic Pain in Rheumatoid Arthritis
- Abstract Number: 1714
The Treatment Gap That Biologic Therapy Cannot Fix: Racial Disparities in Antidepressant Prescribing and Their Consequences on Autoimmune Disease Outcomes – A Propensity matched analysis
- Abstract Number: 2278
The Type I Interferon (IFN-1) Gene Signature Identifies Systemic Lupus Erythematous Patients More Likely to Have Severe Disease Including Activity in Immunologic, Renal and Hematologic Domains
- Abstract Number: 0588
The Updated Sos Project: To Switch Or To Swap After the first TnfA Failure For Childhood Non-Infectious Uveitis
- Abstract Number: 0249
The Vocal Fingerprints of Physical and Oral Frailty in Systemic Sclerosis
- Abstract Number: 1556
Therapeutic Effects of Dry Needling for Patellofemoral Pain Syndrome: An Updated Systematic Review and Meta-Analysis
- Abstract Number: 2573
Three Doses of Once Weekly Retatrutide in Adults with Knee Osteoarthritis and Obesity: An 80-Week, Phase 3 Randomized Clinical Trial
- Abstract Number: 1294
Three-Month Renal Response Markers Associated With Failure to Achieve Complete Renal Response Within 6-12 Months in a Multidisciplinary Lupus Nephritis Clinic
- Abstract Number: 2148
Thyroid Dysfunction Across Different Types of Vasculitis: Is the Thyroid a Potential Target Organ in Microscopic Polyangiitis?
- Abstract Number: 0158
TI-0032: A tLNP-circRNA in vivo CD19 CAR-T Therapy
- Abstract Number: 0642
Tibial Knee Bone Mineral Density Is Prognostic of Change in Medial Joint Space Width: Data from the Osteoarthritis Initiative
- Abstract Number: 2313
Tildrakizumab for the treatment of prior anti-tumor necrosis factor-experienced or -naïve participants with active psoriatic arthritis: pooled Week 24 results of two Phase 3, randomized, double-blind, placebo-controlled studies, INSPIRE 1 and INSPIRE 2
- Abstract Number: 0210
Time Matters in Vasculitis: Evidence Supporting Fast-Track Diagnosis and Early Treatment in ANCA-Associated Vasculitis
- Abstract Number: 1206
Time of ILD onset does not impact on the progression and prognosis of interstitial lung disease in systemic sclerosis: results of a EUSTAR cohort analysis (CP196)
- Abstract Number: 0901
Time Since Last COVID-19 Booster, Rather Than Vaccination Status or Number of Vaccine Doses, Predicts In-Hospital Mortality in Patients With Immune-Mediated Rheumatic Diseases
- Abstract Number: 2875
Time to achieve remission in patients with axial spondyloarthritis initiating a first biologic disease-modifying antirheumatic drug – Results from the EuroSpA collaboration
- Abstract Number: 2149
Time to Disease Relapse After Prolonged Remission in ANCA-Associated Vasculitis
- Abstract Number: 0701
Time to Rheumatology Evaluation and Corticosteroid Burden in Sarcoidosis Patients: A Single Center Study
- Abstract Number: 0211
Time-Dependent Ascending Aortic Remodelling in Eosinophilic Granulomatosis with Polyangiitis: Preliminary Evidence from Cross-Sectional and Longitudinal Echocardiographic Analyses
- Abstract Number: 2516
Time-to-First Uveitis Screening in Newly Diagnosed or Suspected Oligoarticular and Polyarticular Juvenile Idiopathic Arthritis
- Abstract Number: 2279
Time-Varying Proteinuria and Kidney Disease Progression in Lupus Nephritis: A Marginal Structural Model Analysis
- Abstract Number: 2162
Time-Varying Vasodilator and Immunosuppressive Therapy Use and Longitudinal Cardiac Outcomes in Systemic Sclerosis
- Abstract Number: 2945
Timing matters beyond early windows: A comprehensive longitudinal and landmark analysis of disease duration, treatment response, and first biologic drug survival in axial spondyloarthritis
- Abstract Number: 1424
Tirzepatide versus GLP-1 Receptor Agonists and Thromboembolic Risk in Rheumatoid Arthritis with Type 2 Diabetes
- Abstract Number: 2641
Tirzepatide Versus Semaglutide and Risk of Treatment-Defined Flares in Obese Patients With Inflammatory Arthropathies
- Abstract Number: 1243
Title: Sanritatug (Subcutaneous), an anti-CD38 Monoclonal Antibody, Demonstrates Favorable Safety and Promising Efficacy in a Randomized, Double-Blind, Phase 1 Multiple Ascending Dose Study in Active Systemic Lupus Erythematosus (SLE)
- Abstract Number: 2658
Title: The Subtle Sparkle of the Spine: A Case Series on Spinal Pseudogout
- Abstract Number: 0975
TJ-TL23: A Novel Long Half-Life Bispecific Antibody Simultaneously Neutralizing TL1A and IL-23 for Autoimmune Diseases via Synergistic Anti-Inflammation and Anti-Fibrosis
- Abstract Number: 0019
TL1A and TL1A-Driven Inflammatory and Fibrosis Pathways are Upregulated in Sarcoidosis
- Abstract Number: 1049
TL1A defines a focused inflammatory signaling axis in rheumatoid arthritis synovium
- Abstract Number: 0020
TLR2 Drives Pathogenic CD8⁺ T Cell Activation Through Metabolic Reprogramming in Sjögren’s Disease
- Abstract Number: 0054
TLR7/8 Blockade by BMS-905, a Structural Analog of Afimetoran, Drives Transcriptional Rewiring of Kidney Inflammation in a Mouse Model of SLE
- Abstract Number: 1855
TNF inhibitor inadequate response in PsA associates with T cell exhaustion and is overcome by IL32 therapy in humanized mice.
- Abstract Number: 0540
TNF inhibitors and preeclampsia: is there a potential protective effect?
- Abstract Number: 0976
TNFR2 Agonist OD-003 Expands Immunosuppressive Tissue Treg and Has the Potential to Treat Autoimmune and Inflammatory Disease
- Abstract Number: 0763
To Assess and Compare the Performance of Southend GCA Probability Score (GCAPS), Colour Doppler Ultrasound (CDUS) Halo Count and Halo Score to Predict a Final Diagnosis of Giant Cell Arteritis (GCA) in a UK Fast Track Clinic
- Abstract Number: 2517
Tofacitinib For Calcinosis Cutis Associated With Juvenile Dermatomyositis: An Open-Label Single-Arm Study (TOFCAL Study)
- Abstract Number: 2314
Tofacitinib in Early Active Axial Spondyloarthritis: results from the randomized, double-blind, placebo-controlled, multicentre phase IV study, FASTLANE
- Abstract Number: 2546
Tonmya® (Cyclobenzaprine HCl Sublingual Tablets; CBP SL): Efficacy and Safety Analyses of CBP SL 2.8 mg and 5.6 mg in Adults with Fibromyalgia
- Abstract Number: 2547
Tonmya® (TNX-102 SL; Cyclobenzaprine HCI Sublingual Tablets [CBP SL]) for the Treatment of Adults With Fibromyalgia: Number Needed to Treat, Numbers Needed to Harm and Likelihood to be Helped or Harmed: Results From a Pooled Analysis of Two Phase 3 Studies
- Abstract Number: 2870
Toward Improved Patient-Centered Outcome Assessment in SLE Trials: Development of a Novel Patient Reported Outcomes Set by the Lupus Accelerating Breakthroughs Consortium PRO Measures Working Group
- Abstract Number: 0727
Towards Consistent Collection of Patient-reported Outcomes Across a Pediatric Rheumatology Learning Health Network – Defining the Standard
- Abstract Number: 0339
Towards Earlier Recognition of Antimalarial-Induced Cardiomyopathy: Performance of Cardiac Biomarkers
- Abstract Number: 2663
Towards Fast-Track Diagnosis in Autoimmune Diseases: A Systematic Review of Early Detection Pathways Across 14 Disease Groups
- Abstract Number: 1605
Tracheobronchial white plaques: Unveiling the Underestimated Airway Involvement in Anti-MDA5+ Dermatomyositis.
- Abstract Number: 1579
Trajectories of 20-Meter Gait Speed over Eight Years: Data from the Osteoarthritis Initiative (OAI)
- Abstract Number: 0407
Trajectories of Peripheral Arthritis Activity in a Longitudinal Cohort of Individuals with Radiographic Axial Spondyloarthritis
- Abstract Number: 2548
Trajectory of Neuropathic-like and Nociplastic Pain Over Time in Inflammatory Arthritis: Results from the NEUPIA Study
- Abstract Number: 1794
Trajectory-Based Machine Learning Reveals Distinct Phenotypes of Rheumatoid Arthritis
- Abstract Number: 0139
Trans-Disease gut bacteria-metabolite relationships: Results from the AMP AIM Consortium
- Abstract Number: 0285
Transcriptional changes associated with cenerimod therapy, a selective S1PR1 modulator, in systemic lupus erythematosus: analysis from the placebo-controlled Phase 2b CARE trial
- Abstract Number: 2029
Transcriptional mapping of RA heterogeneity: metabolic rewiring and Transposable Elements as key drivers of treatment phenotypes
- Abstract Number: 0008
Transcriptome analysis of temporal artery and aortic lesions highlights vessel-specific chemotaxis and cell adhesion in GCA
- Abstract Number: 0212
Transcriptomic and Immune Programmes Associated with Relapse and Infection Following B-Cell Depletion Therapy in ANCA-Associated Vasculitis
- Abstract Number: 0947
Transcriptomic profiling of systemic lupus (SLE) patients with poor sleep links HPA axis dysfunction to an inflammatory state
- Abstract Number: 1525
Transcriptomic Profiling Reveals Biologically Distinct Subgroups in Newly Diagnosed Children and Adolescents with Systemic Lupus Erythematosus
- Abstract Number: 0116
Transcutaneous Vagus Nerve Stimulation Attenuates Chronic Allodynia and Hyperalgesia in Established PTOA Induced by ACL Rupture in Female Mice
- Abstract Number: 2094
Transient Administration of a Plasma Cell-Depleting BCMAxCD3 Bispecific Antibody Reduces Antigen-Specific Vaccine Titers with Recovery After Revaccination in Humanized BCMA/CD3 Mice
- Abstract Number: 2378
Transition From Conventional to Minimally Invasive Minor Salivary Gland Biopsy in Rheumatology Practice: A Real-World Safety and Feasibility Study
- Abstract Number: 0619
Transition from psoriasis to psoriatic arthritis: Pain perspective from the Turkish National Health Database (e-Nabız)
- Abstract Number: 1526
Transition of Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still’s Disease to Spondyloarthropathy: A Multicenter Retrospective Review of Overlap Syndromes in Pediatric and Adult Rheumatology
- Abstract Number: 0340
Transverse Myelitis/Neuromyelitis Optica in SLE: A Clinical and Immunologic Characterization
- Abstract Number: 2280
Treat-to-Target Implementation and Disease Control in Systemic Lupus Erythematosus in the United States: Real-World Evidence from a Cross-Sectional Survey
- Abstract Number: 2518
Treat-to-Target in DMARD Naive Juvenile Idiopathic Arthritis: 12-month Clinical Outcome of a Randomised Controlled Trial Comparing Methotrexate Monotherapy with Polytherapy: The CHAMP Study
- Abstract Number: 1839
Treat-to-Target Urate-Lowering Treatment and Cardiovascular Disease in Patients with Gout and Chronic Kidney Disease
- Abstract Number: 0607
Treat‑to‑Target Achieved, Fatigue Persists: Cross‑Sectional Insights into Mediators of Residual Fatigue
- Abstract Number: 1295
Treatment Adherence in Patients with SLE Receiving Anifrolumab in Routine Practice: 12-Month Interim Analysis of a Multinational Observational Real-World Study
- Abstract Number: 1425
Treatment History, Prescribing Drivers and Clinical Outcomes with Adalimumab Biosimilar SZ-ADL in Rheumatoid Arthritis: A European Real-World Study
- Abstract Number: 1476
Treatment of pregnant APS patients with certolizumab is associated with decreased Interferon-alpha
- Abstract Number: 1640
Treatment Outcomes With Corticosteroid And Disease Modifying Anti-rheumatic Drugs In Idiopathic Granulomatous Lobular Mastitis : A Single Center Retrospective Observational Study
- Abstract Number: 1641
Treatment outcomes with rilzabrutinib in participants with allergic comorbidities: a post hoc analysis of a phase 2a study in IgG4-related disease
- Abstract Number: 2163
Treatment Patterns for Systemic Sclerosis-Associated Interstitial Lung Disease in the US-based CONQUER Registry
- Abstract Number: 0470
Treatment Patterns in Rheumatoid Arthritis-Associated Interstitial Lung Disease Compared with Other Autoimmune-Associated ILDs: Insights from a Real-World Cohort
- Abstract Number: 0250
Treatment Patterns, Hematologic Response, and Glucocorticoid Exposure in SLE-Associated Hemolytic Anemia: A Real-World Retrospective Cohort Study
- Abstract Number: 0372
Treatment Persistence and Effectiveness Across PsA Patient Subgroups Treated with Guselkumab and IL-17 Inhibitors: 12-Month Findings from the Global PsABIOnd Study
- Abstract Number: 1296
Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): Application to a Phase 3 Trial of Dapirolizumab Pegol
- Abstract Number: 1546
Treatment Satisfaction, Disease Control, and Patient-Defined Treatment Goals Across Myositis Subtypes: An Interim Analysis of a Cross-Sectional Patient-Reported Outcomes Survey
- Abstract Number: 0077
Treatment Steps and Their Outcomes in Difficult-to-Manage Axial Spondyloarthritis: A Retrospective Analysis of ATTRA national Czech registry
- Abstract Number: 0373
Treatment with Glucagon-like Peptide-1 Receptor Agonists is associated with Lower Disease Activity and Pain in Psoriatic Arthritis Independent of Weight Change
- Abstract Number: 2683
Treatment-Refractory Rheumatic Immune-Related Adverse Events are Associated with Adverse Oncological Outcomes: Data from the Multicenter ERIN Registry
- Abstract Number: 1905
TREM2+/SPP1+ macrophages promote fibrotic reprogramming of mesangial cells in lupus nephritis
- Abstract Number: 2281
Trends and Disparities in Cardiovascular Mortality in Systemic Lupus Erythematosus: A CDC WONDER Analysis, 1999-2024
- Abstract Number: 0832
Trends and Disparities in Interstitial Lung Disease-Related Mortality Among U.S. Adults With Systemic Autoimmune Rheumatic Diseases, 2018-2024
- Abstract Number: 0833
Trends and Disparities in Mortality Due to Systemic Connective Tissue Disorders with Coexisting Sepsis in the United States: A 26-Year CDC WONDER Analysis
- Abstract Number: 2007
Trends and Disparities in Systemic Lupus Erythematosus Mortality in the United States, 1999-2020: A Joinpoint Analysis of CDC WONDER National Mortality Data
- Abstract Number: 0589
Trends in Annual Influenza and COVID-19 Vaccination in Childhood Systemic Lupus Erythematosus, 2024-2025
- Abstract Number: 2926
Trends in Giant Cell Arteritis-Associated Mortality in the US, 1999-2024: A Population-Based Analysis of the CDC WONDER MCD Database
- Abstract Number: 0608
Trends in Hospitalizations and Outcomes of Adult-Onset Still’s Disease in the United States (2016-2022) Using the National Inpatient Sample
- Abstract Number: 1477
Trends of Disease-Modifying Antirheumatic Drug Refills among Women with Chronic Inflammatory Arthritis Before, During, and After Pregnancy.
- Abstract Number: 2412
Trial Emulation Comparing Triple Therapy to Etanercept Plus Methotrexate after Methotrexate Failure Using a Real-World Electronic Health Records Data Platform
- Abstract Number: 1244
TRM-SLE disease activity thresholds capture the majority of patients in a Phase 2 clinical trial dataset
- Abstract Number: 2909
Troponin I and NT-pro BNP as useful diagnostic and prognostic biomarkers to monitor cardiac involvement in severe systemic sclerosis treated with autologous haemopoietic stem cell transplantation: A large single Australian centre cohort.
- Abstract Number: 0066
Truncating IDO2 polymorphism is associated with an attenuated interferon gene signature in systemic lupus erythematosus
- Abstract Number: 0055
Twenty Year Longitudinal Assessment of 13 Type I Interferon Antibodies in 675 Lupus Patients: Correlations with disease activity, suppression of interferon responsive genes, patterns of reactivity over time and specificity of antibody binding
- Abstract Number: 2190
Two Distinct Temporal Cancer Phenotypes in Systemic Sclerosis: Age at Onset as a Discriminator of Cancer-Related SSc
- Abstract Number: 2862
Two-Thirds of U.S. Patients with SLE-Attributed End-Stage Kidney Disease Initiate Kidney Replacement Therapy Under Suboptimal Conditions
- Abstract Number: 0899
Two-Week Methotrexate Discontinuation Strategy Enhances Th1-Driven Citokynes Cellular Responses After Recombinant Zoster Vaccination in Autoimmune Rheumatic Diseases Patients
- Abstract Number: 0213
Two-Year Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
- Abstract Number: 1959
Type I Interferon-Mediated Mitochondrial Dysregulation Drives Accumulation of CD25low Regulatory T Cells with Impaired Suppressive Function in Lupus
- Abstract Number: 1115
Type I Interferons and CD40: Complementary Pathways Revealed by mGEDO in Distinct Transcripto-Methylomic Profiles of Patients with Sjögren’s Disease in the PRECISESADS Cohort
ACR Convergence 2026
November 6-11, 2026. Orlando, Florida.